Recross Cardio, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Notable: PROTEA-PFO · (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study Primary completion pushed from Aug 2026 to Aug 2027
- Minor: PROTEA-PFO OUS · Percutaneous Repair Of The Atrial Septum With A Novel PFO Occluder: The PROTEA-PFO OUS Study Study completion pushed from Dec 2029 to Feb 2030
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Heart Disease (2) · Stroke (2)
Get alerts when Recross Cardio, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.